Dandelion root extract shows efficacy against rare leukemia

Researchers from the University of Windsor and Windsor Regional Hospital in Canada have published some potentially important work in the journal PLoS One showing the anti-cancer qualities of dandelion root extract.

Specifically, they have shown how dandelion root extract has the ability to kill cancer cells from the blood of patients diagnosed with a rare, aggressive form of leukemia known as chronic myelomonocyctic leukemia (CMML). Not only did the extract cause the cancer cells to commit suicide, it seemed to leave the healthy cells in the blood alone.

When researchers Dr. Si-yaram Pandey and Dr. Caroline Hamm applied the extract to lab mice with cancer, they saw the same results-- dead cancer cells and untouched, healthy cells and tissue-- a far cry from much of today's anti-cancer regimens, which inevitably cause damage to surrounding healthy tissue and lead to toxicity issues.

The pair of researchers are applying the extract to cells from other cancers, and have another paper primed to be published in the journal of the American Pancreatic Association as well.

The next step is a Phase I human trial to determine safety and tolerability, and Pandey and Hamm have submitted an application to Health Canada for approval.

Source: Calgary Herald

leukemia tretment

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...